Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYCFredrik J. Swartling, William A. Weiss, Vasil Savov et al.|Cancer Cell|2012Cited by 211
Inhibition of Phosphatidylinositol 3-Kinase Destabilizes Mycn Protein and Blocks Malignant Progression in NeuroblastomaLouis Chesler, William A. Weiss|Cancer Research|2006Cited by 198
Pleiotropic role for<i>MYCN</i>in medulloblastomaFredrik J. Swartling, Louis Chesler|Genes & Development|2010Cited by 174
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial resultsKelly C. Goldsmith, Yaël P. Mossé, Lisa J. States et al.|Nature Medicine|2023Cited by 125
Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumorsLynsey Vaughan, Louis Chesler|Oncotarget|2016Cited by 57